Unlock instant, AI-driven research and patent intelligence for your innovation.

Method for purifying anti-S1 protein receptor binding domain polyclonal antibody from plasma of COVID-19 rehabilitative person

A receptor binding domain, polyclonal antibody technology, applied in the field of medicine and biology, can solve the problem that the production of antibodies needs to be improved

Active Publication Date: 2020-12-18
深圳博雅感知药业有限公司
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, it has been found that when using conventional methods (such as antigen-antibody affinity chromatography) to prepare polyclonal antibodies, the yield of antibodies still needs to be improved

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for purifying anti-S1 protein receptor binding domain polyclonal antibody from plasma of COVID-19 rehabilitative person

Examples

Experimental program
Comparison scheme
Effect test

preparation example 1

[0058] Preparation Example 1. Construction of an expression vector having the S1 protein receptor binding domain gene sequence

[0059] 1. The main reagent preparation method

[0060] (1) Plasmid: pGEM-T Easy vector, PET32(a) vector

[0061] (2) Strains: DH5α, BL21

[0062] (3) LB liquid medium: Weigh 5g of Trypton (Trypton), 5g of NaCl, 2.5g of yeast extract, distilled water to a volume of 500mL, autoclave, and store at 4°C for later use.

[0063] (4) LB solid medium: Agar with a final concentration of 20% was added to the above liquid medium.

[0064] (5) Amp / LB medium: When the LB solution is not completely cooled and not hot to the touch, take out the medium and shake it gently to distribute the agar evenly throughout the medium. Subsequently, 250 μl of 1 mg / L Amp was added to 250 mL of culture medium, so that the final concentration of Amp was 100 μg / mL.

[0065] (6) 30% acrylamide storage solution: Weigh 29g of acrylamide and 1g of methylene bisacrylamide, dissolve...

preparation example 2

[0078] Preparation Example 2: Large-scale purification of recombinant protein (S1 protein containing receptor binding domain)

[0079] 1. Preparation of main reagents:

[0080] (1) PMSF (100mmol / L): 17.4mg PMSF dissolved in 1mL isopropanol, stored in -20°C refrigerator;

[0081] (2)NiSO 4 Solution 0.1mol / L 10mL: 0.2629g NiSO 4 Add distilled water to make up to 10mL;

[0082] (3) Equilibrium buffer: 20mmol / L Tris-Cl, pH=7.5, 300mmol / L NaCl;

[0083] (4) 2M imidazole stock solution: add 2.724g imidazole to Tris-Cl solution (20mmol / L, pH=7.5), dilute to 20mL, and store in a refrigerator at 4°C;

[0084] (5) Eluent: ①100mmol / L Tris-Cl (pH7.5) stock solution (1L): dissolve 12.114g Tris in 950mL distilled water, adjust the pH to 7.5 with concentrated HCl, and dilute to 1L; ②2mol / L NaCl 500mL stock solution: dissolve 58.44g NaCl in 450mL distilled water, and dilute to 500mL after complete dissolution;

[0085] (6) Column regeneration solution: ①guanidine hydrochloride solutio...

preparation example 3

[0094] Preparation Example 3: Preparation of S1 Protein Antigen Affinity Chromatography Column

[0095] The invention adopts the purification method of antigen-antibody affinity chromatography to purify the anti-S1 protein receptor binding domain polyclonal antibody. The protein loading capacity of CNBr activated Sepharose™ 4FastFlow filler is 20-60mg / mL. Determine the type of analysis column and the amount of affinity filler according to the amount of protein to be purified.

[0096] Weigh 30 dry powders of CNBr activated Sepharose™ 4 FastFlow filler and dissolve in 100mL of 1mM HCl, then add 500mL of 1mM HCl to rinse the filler until the filler is fully swollen. Rinse the swollen CNBr activated Sepharose™4FastFlow with 500mL Coupling Buffer (0.1MNaHCO3, 0.5M NaCl, pH8.3), and then drain the excess liquid in the filler. First, 1000 mg of S1 protein was dialyzed in Coupling Buffer, then the swollen CNBr activated Sepharose™ 4 FastFlow filler was added to the S1 protein sol...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a method for purifying an anti-S1 protein receptor binding domain polyclonal antibody from plasma of a COVID-19 rehabilitative person. The method for preparing an anti-S1 protein receptor binding domain polyclonal antibody preparation comprises the following steps of providing an S1 receptor protein antigen-antibody affinity chromatographic column; rapidly separating peripheral blood obtained from a patient in a COVID-19 rehabilitation period by utilizing a closed automatic separation system for the multi-cell components so as to obtain plasma components; and preparingand purifying the anti-S1 protein receptor binding domain polyclonal antibody from the obtained plasma by using the S1 receptor protein antigen-antibody affinity chromatography column to obtain the anti-S1 protein receptor binding domain polyclonal antibody product. The methods of the invention exhibit excellent technical effects as described in the specification, for example, with considerably high antibody yields.

Description

technical field [0001] The invention belongs to the field of medical biotechnology, and specifically relates to a method for rapidly separating plasma components from whole blood to prepare polyclonal antibodies against S1 protein receptor binding domains. In particular, it relates to a method for rapidly extracting convalescent plasma from COVID-19 patients by using a closed multi-cell component automatic separation system to prepare polyclonal antibodies against the S1 protein receptor binding domain. In particular, it involves the use of a closed multicomponent automated cell separation system, namely the Multicomponent Automated Cell Separation System (MACSS, ThermoGenesis Corp.), to rapidly separate plasma components from whole blood and then prepare polyclonal antibodies against the S1 protein receptor binding domain. The polyclonal antibody against the S1 protein receptor binding domain can be used for the treatment of patients infected with the novel coronavirus COVID-...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K16/10C07K16/06C07K1/36C07K1/34C07K1/22A61K39/395A61P31/14
CPCA61K2039/505A61P31/14C07K16/065C07K16/10C07K2317/35
Inventor 魏卿肖海蓉刘庆喜
Owner 深圳博雅感知药业有限公司